Sediqe Shafiei | Oral Health Award | Best Researcher Award

Assist Prof Dr. Sediqe Shafiei | Oral Health Award | Best Researcher Award

Assist Prof Dr. Sediqe Shafiei, Shahid Beheshti University of Medical Sciences(SBMU), Iran

Assist. Prof. Dr. Sediqe Shafiei is a dedicated academic and researcher in the field of Preventive and Community Oral Health ๐Ÿฆท๐Ÿ“˜. She has a distinguished career at the School of Dentistry, Shahid Beheshti University of Medical Sciences, Iran ๐Ÿ‡ฎ๐Ÿ‡ท. With a DDS and PhD, Dr. Shafiei has contributed to numerous research projects, including socioeconomic status and oral health studies ๐Ÿ“Š๐Ÿ”. Her work in developing educational tools for hearing-impaired children demonstrates her commitment to community health ๐Ÿ“ฑ๐Ÿง’. A board member of the Oral Health Association of Iran, Dr. Shafiei continues to make significant contributions to her field ๐ŸŒŸ.

Publication profile

Orcid

Academic and Professional Background ๐Ÿ“š๐Ÿ‘ฉโ€โš•๏ธ

Dr. Sediqe Shafiei, an Assistant Professor at the School of Dentistry, Shahid Beheshti University of Medical Sciences (SBMU), has a rich history in Preventive Dentistry. From February 1999 to January 2014, she worked in health centers, followed by a PhD in Community and Oral Health (2014-2019). Since August 2021, she has been a faculty member in the Community Oral Health Department.

Research Focus

Assist. Prof. Dr. Sediqe Shafiei primarily focuses on public health and oral health research, particularly within the context of socioeconomic factors and their impact on health outcomes in Iran. Her studies delve into how socioeconomic status influences oral health-related quality of life, as evidenced by her development of a socioeconomic status index tool ๐Ÿก๐Ÿ“Š. Additionally, Dr. Shafiei explores barriers to promoting oral health in vulnerable populations, such as students with hearing impairments ๐ŸŽ“๐Ÿฆป. Her work is pivotal in understanding and improving health disparities, ensuring better community health and well-being through targeted educational and policy interventions ๐Ÿ“š๐Ÿ’ก.

Publication Top Notes

Impact of Awareness Obtained from Studying Dentistry on Oral Health-Related Quality of Life at Shahid Beheshti University

Investigating Barriers to Promoting Oral Health in Students with Hearing Impairment from Mothers’ Perspective: A Qualitative Content Analysis

Measurement components of socioeconomic status in health-related studies in Iran

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Jianglan Long | Medicine and Dentistry | Best Innovation Award

Dr Jianglan Long,Beijing Institute of Clinical Pharmacy, Beijing Friendship Hospital, Capital Medical University,China

Dr. Jianglan Long is a dedicated Researcher Intern at Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital and Capital Medical University. Specializing in intelligent molecular diagnostics and drug intervention mechanisms for pre-diabetes and type 2 diabetes, Dr. Long has published several impactful papers. Notable works include studies in International Journal of Biological Macromolecules (2024) on innovative diabetes treatments, and contributions to Diabetes Obesity & Metabolism (2024) on predictive biomarker profiling. Dr. Long is a pioneer in developing integrated diagnostic tools and advancing diabetes treatment in China. ๐ŸŒŸ๐Ÿ”ฌ๐Ÿ“š

Publication profile

Scopus

Academic and Professional Background

Dr. Jianglan Long is a prominent researcher based at the Beijing Institute of Clinical Pharmacy, affiliated with Beijing Friendship Hospital, Capital Medical University. His primary focus lies in the exploration of intelligent molecular diagnosis and drug intervention mechanisms for prediabetes and type 2 diabetes. Dr. Jianglan Long has made significant contributions to this field, evidenced by his publications in reputable journals such as the International Journal of Biological Macromolecules (2024), Diabetes Obesity & Metabolism (2024), Clinical and Translational Medicine (2021), BMC Endocrine Disorders (2020), and Rapid Communications in Mass Spectrometry (2020), where he served as the first author.

 

Research focus

Category: Research Focus on Intelligent Molecular Diagnosis and Drug Intervention for Diabetes

Jianglan Long’s research centers on advancing the field of intelligent molecular diagnostics and drug interventions for pre-diabetes and type 2 diabetes. Her work includes pioneering biomarker profiling for early disease detection and the enhancement of metformin therapy with innovative treatments, like low molecular weight polysaccharides from Astragalus membranaceus. With twelve published journals and ongoing research, her contributions are crucial for improving diabetes management and treatment outcomes in China and potentially worldwide. ๐Ÿ“Š๐Ÿ”ฌ๐Ÿ’Š๐ŸŒ

Publication top notes

Structural characterization of Astragalus polysaccharide-D1 and its improvement of low-dose metformin effect by enriching Staphylococcus lentus

Uncovering the key pharmacodynamic material basis and possible molecular mechanism of Xiaoke formulation improve insulin resistant through a comprehensive investigation

Rapid multichannel fluorescent probe assay for CYP450 inhibition screening and drug interaction monitoring

Novel weight loss diet attenuates dietary-induced obesity in mice and might correlate with altered gut microbiota and metabolite profiles

Polystyrene microplastic exposure induces insulin resistance in mice via dysbacteriosis and pro-inflammation

Evaluation of interaction of chlorogenic acid and cefotaxime sodium based on sequential analysis

Network pharmacology-based dissection of the underlying mechanisms of dyspnoea induced by zedoary turmeric oil

Metabolomics based plasma biomarkers for diagnosis of oral squamous cell carcinoma and oral erosive lichen planus